|
Volumn 47, Issue 3, 2002, Pages 207-213
|
Abnormal and dysfunctional uterine bleeding
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
CONJUGATED ESTROGEN;
CORTICOSTEROID;
DANAZOL;
ESTRADIOL;
ESTROGEN;
GESTAGEN;
IBUPROFEN;
IRON;
MEDROXYPROGESTERONE ACETATE;
MEFENAMIC ACID;
NAPROXEN;
NEUROLEPTIC AGENT;
ORAL CONTRACEPTIVE AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADOLESCENT;
ADRENAL DISEASE;
ADULT;
ANAMNESIS;
ARTICLE;
AUTOIMMUNE DISEASE;
BLEEDING;
BLOOD CLOTTING DISORDER;
CONTROLLED STUDY;
CURETTAGE;
DIFFERENTIAL DIAGNOSIS;
DRUG COST;
ENDOCRINE DISEASE;
FEMALE;
GENITAL SYSTEM DISEASE;
HUMAN;
INFECTION;
KIDNEY DISEASE;
LABORATORY TEST;
LIFESTYLE;
LIVER DISEASE;
OVARY POLYCYSTIC DISEASE;
PHYSICAL EXAMINATION;
PREGNANCY COMPLICATION;
SYSTEMIC DISEASE;
UTERUS BLEEDING;
UTERUS DISEASE;
MENSTRUATION DISORDER;
MIDDLE AGED;
REVIEW;
ADOLESCENT;
ADULT;
CONTRACEPTIVES, ORAL, COMBINED;
DIAGNOSIS, DIFFERENTIAL;
ESTROGENS;
FEMALE;
HUMANS;
MENSTRUATION DISTURBANCES;
MIDDLE AGED;
PROGESTINS;
UTERINE HEMORRHAGE;
|
EID: 0036263053
PISSN: 15269523
EISSN: None
Source Type: Journal
DOI: 10.1016/S1526-9523(02)00229-5 Document Type: Note |
Times cited : (2)
|
References (34)
|